Acrivon Therapeutics
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. T...
Acrivon Therapeutics Logo
About Acrivon Therapeutics
Acrivon Therapeutics, Inc. is a clinical stage oncology company. The Company offers a predictive precision proteomics technology platform which enables the development of drug-tailored companion diagnostics that link drug mechanisms to the active disease-driving processes of cancer in patients, uncovering drug sensitivity not achievable through traditional genomics analyses.
Address
480 Arsenal Way, Suite 100
Watertown, 02472
United States
Year founded
2018
Number of employees
0-100
Report inaccurate data
Request an update to help us keep the brand up-to-date.
